MK-0928 [gaboxadol] phase II sleep laboratory study - primary insomnia
Latest Information Update: 05 May 2022
At a glance
- Drugs Gaboxadol - Ovid Therapeuticsgaboxadol (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- 16 Sep 2006 New trial record.